Mesenchymal Stem Cell Transplantation
"Mesenchymal Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).
| Descriptor ID |
D045164
|
| MeSH Number(s) |
E02.095.147.500.500.625 E04.936.225.687.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesenchymal Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Mesenchymal Stem Cell Transplantation".
This graph shows the total number of publications written about "Mesenchymal Stem Cell Transplantation" by people in this website by year, and whether "Mesenchymal Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 5 | 0 | 5 |
| 2009 | 5 | 2 | 7 |
| 2010 | 7 | 1 | 8 |
| 2011 | 10 | 2 | 12 |
| 2012 | 4 | 0 | 4 |
| 2013 | 10 | 2 | 12 |
| 2014 | 4 | 2 | 6 |
| 2015 | 7 | 2 | 9 |
| 2016 | 6 | 2 | 8 |
| 2017 | 6 | 1 | 7 |
| 2018 | 5 | 2 | 7 |
| 2019 | 6 | 0 | 6 |
| 2020 | 6 | 0 | 6 |
| 2021 | 4 | 4 | 8 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesenchymal Stem Cell Transplantation" by people in Profiles.
-
Integration of Electrospun Scaffolds and Biological Polymers for Enhancing the Delivery and Efficacy of Mesenchymal Stem/Stromal Cell Therapies. Front Biosci (Landmark Ed). 2024 Jun 24; 29(6):228.
-
MegaPro, a clinically translatable nanoparticle for in vivo tracking of stem cell implants in pig cartilage defects. Theranostics. 2023; 13(8):2710-2720.
-
Mesenchymal stromal cell-derived syndecan-2 regulates the immune response during sepsis to foster bacterial clearance and resolution of inflammation. FEBS J. 2022 01; 289(2):417-435.
-
A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease. Stem Cells Transl Med. 2021 09; 10(9):1304-1319.
-
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol. 2021; 12:631353.
-
Ascorbic Acid and Iron Supplement Treatment Improves Stem Cell-Mediated Cartilage Regeneration in a Minipig Model. Am J Sports Med. 2021 06; 49(7):1861-1870.
-
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021 Apr 14; 28(1):28.
-
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. 2021 04; 23(4):661-674.
-
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity. Mol Ther. 2021 05 05; 29(5):1808-1820.
-
Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits. Theranostics. 2021; 11(7):3109-3130.